A Phase III, Randomized, Placebo-Controlled, Double-Blind Trial of Flaxseed for the Treatment of Hot Flashes: NCCTG N08C7
      QxMD      Google Scholar   
Citation:
Menopause vol 19 (1) 48-53
Year:
2012
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
828  
Children:
None
Program:
CCP
Primary Committee:
Symptom Inter
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA037404-25, U10 CA035267, U10 CA037417, N01 CA035431, U10 CA035269, CA-37404, K05 CA124477, U10 CA037404, N01 CA035119, U10 CA035448, U10 CA063848, CA-25224, CA-35113, U10 CA035113, CA-63848, U10 CA035415, U10 CA063849, CA-35415, U10 CA035431, U10 CA035119, CA-37417, CA-35269, CA-35448, U10 CA025224, CA-35267, CA-63849  
Corr. Author:
 
Authors:
                           
Networks:
 
Study
NCCTG-N08C7
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
flaxseed, dietary supplement, hot flashes, menopause, clinical trial